Piedmont Cancer Institute is a clinical research site located in Atlanta, Georgia, United States 30309.
Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.
Piedmont Cancer Institute has participated in 27 clinical trials with 11 currently active.
Therapeutic areas: HER2 Positive Breast Neoplasms, Hormone Receptor Positive Breast Neoplasms, Triple Negative Breast Neoplasms.
Sponsors: Seagen Inc., Pfizer, Astellas Pharma Global Development, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Georgia · View every site in Atlanta
Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Piedmont Cancer Institute has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Piedmont Cancer Institute has 27 clinical trials on record, with 11 currently active. Their work covers HER2 Positive Breast Neoplasms, Hormone Receptor Positive Breast Neoplasms, Triple Negative Breast Neoplasms.
Piedmont Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.